While the German activities tend to be very positive, they appear inappropriate given Germany’s economic clout and its significance as a centre of research.

Can the recent Ebola outbreak give a boost to R&D funding?
If any good is to come of this horrible epidemic, it is to show that infectious diseases are not static but develop relatively dynamically and in a globalised world can also affect the industrialised countries. One example here is tuberculosis, which we long believed to have eradicated; now we are witnessing a sort of comeback in Europe, albeit not of an alarming magnitude. In the course of climate change, controlling vectors, such as those of malaria, will certainly also have to be considered.

How are the worst affected countries contributing to disease eradication?
In many low- and middle-income countries, the research budgets are simply too small. Nevertheless, the potential of institutions there should not be underestimated.